Comparison of the Effectiveness of Walking Back Exercises and Rebound Therapy in Cerebral Palsy Rehabilitation

Not Applicable

• Conditions: Cerebral Palsy, Spastic
• Interventions: Other: rebound therapy

• Registration Number: NCT04694118
• Lead Sponsor: Istanbul Medipol University Hospital

Brief Summary

Purpose of the study:

To investigate the effect of walking back exercises and rebound therapy on muscle strength, functionality, balance and aerobic capacity in children with CP Implication for rehabilitation:Determining the effects of rehabilitative interventions (back and forth walking exercises and rebound therapy) to be applied in children with CP with objective measurement methods (muscle US, tetrax balance system) and evaluating the effects of the results on functionality and respiratory parameters

Detailed Description

Inclusion Criteria:

Being diagnosed with SP To be in the age range of 6-15 years, where effective communication can be provided in evaluation and treatment processes and when walking begins to mature Having adequate communication skills Being on level I or level II according to GMFM No impairment in visual functions in terms of not affecting postural control responses, Children with family consent

Study design:

Application of the evaluation methods specified at the beginning of the study to all 30 patients with CP who were randomly divided into 2 groups.

Re-evaluations were planned 8 weeks after the first evaluation of all cases who were continuing with structured neurodevelopmental treatment programs. In addition to the ongoing structured neurodevelopmental treatment programs; Group 1: 12 weeks / 3 days 20 minutes walking back exercises on normal ground, Group 2: Rebound therapy exercises, which are arranged according to the functional levels of the cases, will be applied in 12 weeks / 3 days for 20 minutes.

Study Timeline

• Status Verified: 2021-01
• Study First Submitted: 2021-01-01
• Study First Submitted QC: 2021-01-01
• Study Start: 2021-01-04
• Study First Posted: 2021-01-05
• Last Update Submitted: 2021-01-05
• Last Update Posted: 2021-01-06
• Primary Completion: 2021-12-15
• Study Completion: 2021-12-15

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

• Being diagnosed with hemiparetic SP To be in the age range of 6-15 years, where effective communication can be provided in evaluation and treatment processes and when walking begins to mature Having adequate communication skills Being on level I or level II according to KMFSS No impairment in visual functions in terms of not affecting postural control responses, Children with family consent

Exclusion Criteria

• Orthopedic surgery and / or botulinum toxin-A application for the lower extremity in the last 6 months Being at level III, level IV or level V according to KMFSS Severe convulsion situations that cannot be controlled with drugs Presence of a medical condition that prevents participation in the study Congenital malformation conditions accompanying CP

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
15 hemiparetic cerebral palsy,rebound therapy group	rebound therapy	GMFM I or II degreed 6-15 age range hemiparetic cerebral palsy
15 hemiparetic cerebral palsy,walking back group	rebound therapy	GMFM I or II degreed 6-15 age range hemiparetic cerebral palsy

Primary Outcome Measures

Name	Time	Method
changes in muscle volume	one measurement at the beginning of the study, second measurement 8 weeks later, 3rd measurement at 12th week following	ultrasonic imaging

Trial Locations

Locations (2)

Ulku Atasoy; 🇹🇷 İstanbul, Ümraniye, Turkey

Umran medical center; 🇹🇷 İstanbul, Uskudar, Turkey